Levovirin

DB06523ExperimentalSmall molecule

Investigated for use/treatment in hepatitis (viral, C).

Chemical structure of Levovirin
Primary indication
Investigated for use/treatment in hepatitis (viral, C).Curator reviewed
Formula / weight
C8H12N4O5 · 244.207 g/mol (avg)
Code names
ICN-17261 · R1270

Resolves to

Compound
UNIIZGF0S6S33QCAS206269-27-4ChEMBLCHEMBL274536
Structure
InChIKeyIWUCXVSUMQZMFG-RGDLXGNYSA-NSMILESNC(=O)C1=NN(C=N1)[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O

Which companies are running trials of Levovirin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In